Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Pierce Group PIERCE Apr 25, 2025 9.40 +8.29   
 Pila Pharma PILA Apr 25, 2025 3.19 +5.11   
 PION Group AB PIONB Apr 25, 2025 5.82 +0.34   
 PixelFox PIXEL Apr 25, 2025 0.81 +0.62   
 Platzer Fastigheter Holding AB (publ) PLAZB Apr 25, 2025 75.60 +1.07   
 Plejd PLEJD Apr 25, 2025 582.00 +1.75   
 PolarCool POLAR Apr 25, 2025 5.50 -3.51   
 Polygiene POLYG Apr 25, 2025 9.90 +6.45   
 Polyplank POLY Apr 25, 2025 0.04 -3.23   
 PowerCell Sweden PCELL Apr 25, 2025 24.64 -6.24   
 Prebona PREBON Apr 25, 2025 2.10 +0.96   
 Precio Fishbone B PRCOB Apr 25, 2025 21.80 -4.39   
 Precise Biometrics PREC Apr 25, 2025 4.42 +4.39   
 Precomp Solutions B PCOMB Apr 25, 2025 0.86 +0.58   
 Premium Snacks Nordic SNX Apr 25, 2025 26.50 +6.85   
 Preservia Hyresfastigheter B PHYRB Apr 25, 2025 0.13 0.00   
 Preservium Property PRESRV Apr 25, 2025 35.00 +30.60   
 Prevas B PREVB Apr 25, 2025 98.50 +0.35   
 Pricer B PRICB Apr 25, 2025 5.89 +0.68   
 Prisma Properties AB PRISMA Apr 25, 2025 24.11 -2.01   
 Proact IT Group PACT Apr 25, 2025 117.80 0.00   
 ProfilGruppen B PROFB Apr 25, 2025 117.56 +3.12   
 Profoto Holding PRFO Apr 25, 2025 26.00 +0.78   
 Projektengagemang Sweden B PENGB Apr 25, 2025 7.34 +2.80   
 Prolight Diagnostics PRLD Apr 25, 2025 0.40 +3.95   
 Promimic AB PRO Apr 25, 2025 26.30 +9.58   
 ProstaLund PLUN Apr 25, 2025 7.15 -2.72   
 Prostatype Genomics PROGEN Apr 25, 2025 1.94 +1.57   
 Provide IT PROVIT Apr 25, 2025 1.44 +5.88   
 Purefun PURE Apr 25, 2025 11.80 -7.45   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.